The art of finding the right drug target: emerging methods and strategies

ZC Jia, X Yang, YK Wu, M Li, D Das, MX Chen… - Pharmacological …, 2024 - Elsevier
Drug targets are specific molecules in biological tissues and body fluids that interact with
drugs. Drug target discovery is a key component of drug discovery and is essential for the …

Disrupting pathologic phase transitions in neurodegeneration

BT Hurtle, L Xie, CJ Donnelly - The Journal of clinical …, 2023 - Am Soc Clin Investig
Solid-like protein deposits found in aged and diseased human brains have revealed a
relationship between insoluble protein accumulations and the resulting deficits in neurologic …

Pathogenic tau induces an adaptive elevation in mRNA translation rate at early stages of disease

G Zuniga, S Katsumura, J De Mange, P Ramirez… - Aging cell, 2024 - Wiley Online Library
Alterations in the rate and accuracy of messenger RNA (mRNA) translation are associated
with aging and several neurodegenerative disorders, including Alzheimer's disease and …

A genome‐wide association meta‐analysis of all‐cause and vascular dementia

Mega Vascular Cognitive Impairment and … - Alzheimer's & …, 2024 - Wiley Online Library
INTRODUCTION Dementia is a multifactorial disease with Alzheimer's disease (AD) and
vascular dementia (VaD) pathologies making the largest contributions. Yet, most genome …

The Role of Retrotransposons and Endogenous Retroviruses in Age-Dependent Neurodegenerative Disorders

B Frost, J Dubnau - Annual Review of Neuroscience, 2024 - annualreviews.org
Over 40% of the human genome is composed of retrotransposons, DNA species that hold
the potential to replicate via an RNA intermediate and are evolutionarily related to …

[HTML][HTML] Tau-induced elevation of the activity-regulated cytoskeleton associated protein Arc1 causally mediates neurodegeneration in the adult Drosophila brain

L Schulz, P Ramirez, A Lemieux, E Gonzalez… - Neuroscience, 2023 - Elsevier
Alzheimer's disease and other tauopathies are neurodegenerative disorders pathologically
defined by aggregated forms of tau protein in the brain. While synaptic degradation is a well …

Selective neuronal vulnerability to deficits in RNA processing

G Zuniga, B Frost - Progress in Neurobiology, 2023 - Elsevier
Emerging evidence indicates that errors in RNA processing can causally drive
neurodegeneration. Given that RNA produced from expressed genes of all cell types …

Enhancing proteasome activity by NMDAR antagonists explains their therapeutic effect in neurodegenerative and mental diseases

F Sahin, A Gunel, BT Atasoy, U Guler, B Salih, I Kuzu… - Scientific Reports, 2025 - nature.com
NMDAR antagonists, such as memantine and ketamine, have shown efficacy in treating
neurodegenerative diseases and major depression. The mechanism by which these drugs …

[HTML][HTML] Multifaceted Role of Specialized Neuropeptide-Intensive Neurons on the Selective Vulnerability to Alzheimer's Disease in the Human Brain

M Li, N Flack, PA Larsen - Biomolecules, 2024 - mdpi.com
Regarding Alzheimer's disease (AD), specific neuronal populations and brain regions
exhibit selective vulnerability. Understanding the basis of this selective neuronal and …

[HTML][HTML] Brain Plasticity and Cell Competition: Immediate Early Genes Are the Focus

PP Tregub, YK Komleva, MV Kukla, AS Averchuk… - Cells, 2025 - mdpi.com
Brain plasticity is at the basis of many cognitive functions, including learning and memory. It
includes several mechanisms of synaptic and extrasynaptic changes, neurogenesis, and the …